戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion with synapses via a mechanism involving apolipoprotein E receptors.
2                  We investigated the role of Apolipoprotein E receptor 2 (ApoER2') on the pathogenic
3 elin and VLDLR was similar but expression of apolipoprotein E receptor 2 (ApoER2) (the reelin recepto
4      Here we report, that clusterin binds to apolipoprotein E receptor 2 (ApoER2) and very low densit
5  through the canonical lipoprotein receptors apolipoprotein E receptor 2 (Apoer2) and very low-densit
6 s by binding to two transmembrane receptors, apolipoprotein E receptor 2 (Apoer2) and very-low-densit
7  identification of bound proteins identified apolipoprotein E receptor 2 (ApoER2) as a candidate test
8 low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2) as cellular recepto
9 density lipoprotein receptor (VLDLR) and the apolipoprotein E receptor 2 (ApoER2) exhibit identical n
10                                        Human apolipoprotein E receptor 2 (APOER2) is a type I transme
11                                 The proteins apolipoprotein E receptor 2 (ApoER2) isoforms 1 and 2, a
12 low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (apoER2) results in either p
13 carrying apolipoprotein E (ApoE) to receptor apolipoprotein E receptor 2 (ApoER2) triggers the endocy
14 . apoE3, and also greater risk with the LRP8/apolipoprotein E receptor 2 (ApoER2) variant ApoER2-R952
15                                              Apolipoprotein E receptor 2 (Apoer2), a member of the LD
16    Selenoprotein P (Sepp1) and its receptor, apolipoprotein E receptor 2 (apoER2), account for brain
17 se models with genetic deletion of Reelin or apolipoprotein E receptor 2 (Apoer2), as well as pharmac
18 low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2), but the exact mech
19 e ligand-binding domains (LBDs) of VLDLR and apolipoprotein E receptor 2 (ApoER2), two closely relate
20 low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2), which are recogniz
21  human monocytic-like U937 cells to evaluate apolipoprotein E receptor 2 (ApoER2)-dependent signaling
22 ow-density lipoprotein receptors (VLDLR) and apolipoprotein E receptor 2 (ApoER2).
23 low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2).
24 low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2).
25 ow density lipoprotein receptor (VLDLR), the apolipoprotein E receptor 2 (ApoER2; refs 9-11 ), alpha3
26 low density lipoprotein receptor family, the apolipoprotein E receptor 2 and the very low density lip
27 ls, triggers a signal in granulosa cells via apolipoprotein E receptor 2 and the very low density lip
28 lipids and with the intracellular domains of apolipoprotein E receptor 2 and very low density lipopro
29 ery low density lipoprotein receptor and the apolipoprotein E receptor 2 on the surface of neurons.
30 r very-low-density lipoprotein receptors and apolipoprotein E receptor 2 receptors but by a distinct
31 itiated by reelin and its receptors, apoER2 (apolipoprotein E receptor 2) and VLDLR (very-low-density
32 -low-density lipoprotein receptors (VLDL-R), apolipoprotein E receptor 2, LRP, and megalin.
33 s, very low-density lipoprotein receptor and apolipoprotein E receptor 2, the cytoplasmic adaptor pro
34 he very low density lipoprotein receptor and apolipoprotein E receptor 2, thereby inducing tyrosine p
35 s, very-low-density lipoprotein receptor and apolipoprotein E receptor 2, to stimulate phosphorylatio
36 c evidence that this cascade is dependent on apolipoprotein E receptor 2, very low density lipoprotei
37 th very low density lipoprotein receptor and apolipoprotein E receptor 2.
38 ic alterations of Sepp1, the Sepp1 receptors apolipoprotein E receptor-2 (apoER2) and megalin, and Gp
39                     The lipoprotein receptor apolipoprotein E receptor-2 (apoER2) binds Sepp1 and fac
40                We recently demonstrated that apolipoprotein E receptor-2 (ApoER2) is required for Sep
41                                          The apolipoprotein E receptor-2 (apoER2), also called LR7/8B
42 ow density lipoprotein receptor (VLDLR), the apolipoprotein E receptor-2 (apoER2), and megalin.
43 es take up plasma Sepp1 for its selenium via apolipoprotein E receptor-2 (apoER2)-mediated endocytosi
44 density lipoprotein receptor (VLDLR) and the apolipoprotein E receptor-2 (apoER2).
45 on to their expression of the Sepp1 receptor apolipoprotein E receptor-2, creating a tissue selenium
46                                        These Apolipoprotein E receptors are highly expressed in the d
47 nctionalized with a peptide derived from the apolipoprotein-E receptor-binding domain for blood-brain
48 lin-dependent kinase 2 (CDK2) in carotids of apolipoprotein-E receptor null (ApoE(-/-)) mice and in C
49 e repeat in the 5' untranslated region of an apolipoprotein E receptor, the very-low-density lipoprot